CIK 0001822791 · Non-accelerated filer<br>Smaller reporting company
Clene Inc.
Sign in to watch- Ticker
- CLNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 852828339
- Phone
- 801-676-9695
- Business address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Former names
- Chelsea Worldwide Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-30 | Ugwumba Chidozie 10% owner | Grant or award · Warrants (Right to buy) | +424,358 | 424,358 | ||
| 2024-09-30 | Mortenson Mark Chief Science Officer | Purchase | +20,512 | $4.75 | $97K | 28,949 |
| 2024-09-30 | Mortenson Mark Chief Science Officer | Grant or award · Warrants (Right to buy) | +20,512 | $0.13 | $3K | 20,512 |
| 2024-09-30 | Etherington Robert Dee Chief Executive Officer | Purchase | +10,000 | $4.75 | $48K | 40,149 |
| 2024-09-30 | Etherington Robert Dee Chief Executive Officer | Grant or award · Warrants (Right to buy) | +10,000 | $0.13 | $1K | 10,000 |
| 2024-08-16 | Mortenson Mark Chief Science Officer | Grant or award · Stock Options (Right to buy) | +25,000 | 25,000 | ||
| 2024-08-16 | Etherington Robert Dee Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +25,000 | 25,000 | ||
| 2024-08-16 | BROWN MORGAN R Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +10,000 | 10,000 | ||
| 2024-07-29 | Etherington Robert Dee Chief Executive Officer | Option exercise | +27,320 | $3.00 | $82K | 30,149 |
| 2024-07-29 | Etherington Robert Dee Chief Executive Officer | Option exercise · Stock Options (Right to buy) | +27,320 | 27,319 | ||
| 2024-06-07 | BROWN MORGAN R Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +400,000 | 400,000 | ||
| 2024-06-07 | BROWN MORGAN R Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +600,000 | 600,000 | ||
| 2024-06-07 | McLaughlin Vallerie Director | Grant or award · Stock Options (Right to buy) | +37,074 | 37,074 | ||
| 2024-06-07 | Jacobovitz Shalom Director | Grant or award · Stock Options (Right to buy) | +50,135 | 50,135 | ||
| 2024-06-07 | MATLIN DAVID J Director | Grant or award · Stock Options (Right to buy) | +65,723 | 65,723 | ||
| 2024-06-07 | Desai Arjun JJ Director | Grant or award · Stock Options (Right to buy) | +38,760 | 38,760 | ||
| 2024-06-07 | Mortenson Mark Chief Science Officer | Grant or award · Stock Options (Right to buy) | +2,000,000 | 2,000,000 | ||
| 2024-06-07 | Mortenson Mark Chief Science Officer | Grant or award · Stock Options (Right to buy) | +800,000 | 800,000 | ||
| 2024-06-07 | Etherington Robert Dee Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +900,000 | 900,000 | ||
| 2024-06-07 | Etherington Robert Dee Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +2,250,000 | 2,250,000 |
Page 11 of 15 · 292 trades